Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT(1A) and V2 receptors

Cellular Signalling

Volumn 10, Issue 1, 1998, Pages 65-74

  Klingler, C ^a   Ancellin, N ^a   Barrault, M B ^a   Morel, A ^a   Buhler, J M ^a   Elalouf, J M ^a   Clauser, E ^b   Lugnier, C ^c   Corman, B ^a  

^a DIF   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Angiotensin II; Calcium; cAMP; Intracellular signalling; Phosphodiesterases; Vasopressin

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CALCIUM CHELATING AGENT; CALCIUM ION; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FORSKOLIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; THAPSIGARGIN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CHO CELL; CONTROLLED STUDY; DNA TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; CYCLIC AMP; FORSKOLIN; INTRACELLULAR FLUID; PHOSPHORIC DIESTER HYDROLASES; PROTEIN KINASE C; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RECEPTORS, VASOPRESSIN; TRANSFECTION; VASOPRESSINS;

ANIMALIA;

EID: 0031973029     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(97)00077-6     Document Type: Article

References (26)

1. Firsov D., Mandon B., Morel A., Merot J., Le Maout S., Bellanger A. C., de Rouffignac C., Elalouf J. M., Bhuler J. M. Pflügers Arch. Eur. J. Physiol. 429:1994;79-89.
2. Kakinuma Y., Fogo A., Inagami T., Ichikawa I. Kidney Int. 43:1993;1229-1235.
3. Meister B., Lippoldt A., Bunnemann B., Inagami T., Ganten D., Fuxe K. Kidney Int. 44:1993;331-336.
4. Terada Y., Tomita K., Nonoguchi H., Marumo F. Kidney Int. 43(6):1993;1251-1259.
5. Cooper D., Mons N., Fagan K. Cell. Signal. 6(8):1994;823-840.
6. Edwards R., Stack E. J. Pharmacol. Exp. 266:1993;506-510.
7. Jard S., Cantau B., Jakobs H. J. Biol. Chem. 256(6):1981;2603-2606.
8. Marie J., Gaillard R., Schoenenberg P., Jard S., Bockaert J. Endocrinology. 116:1985;1044-1050.
9. Nabika T., Nara Y., Yamori Y., Lovenberg W., Endo J. Biochem. Biophys. Res. Commun. 131:1985;30-36.
10. Johnson M., Aguilera G. Endocrinology. 131:1992;2404-2412.
11. Boarder M., Plevin R., Marriott D. J. Biol. Chem. 263(30):1988;15319-15324.
12. Teutsch B., Bihoreau C., Monnot C., Bernstein K. E., Murphy T. J., Alexander R. W., Corvol P., Clauser E. Biochem. Biophys. Res. Commun. 187:1992;1381-1388.
13. Bihoreau C., Monnot C., Davies E., Teutsch B., Bernstein K., Corvol P., Clauser E. Proc. Natl. Acad. Sci. 90:1993;5133-5137.
14. Pradelles P., Grassi J., Chabardes D., Guiso N. Analytical Chemistry. 61:1989;447-453.
15. Keravis T. M., Wells J. N., Hardman J. G. Biochim. Biophys. Acta. 613:1980;116-129.
16. Lugnier C., Komas N. Eur. Heart J. 14(suppl I):1993;141-148.
17. Fabiato A. (1989) In: Methods in Enzymology, Membrane (Fleischer S. and Fleischer B., Eds) 157, pp. 378-417. Academic Press, Orlando, FL.
18. Bradford M. M. Anal. Biochem. 72:1976;248-254.
19. Hansen C. A., Monck J. R., Williamson J. R. Methods Enzymol. 191:1990;691-706.
20. Brynkiewicz G., Poenie M., Tsien R. Y. J. Biol. Chem. 360:1985;3440-3450.
21. Beavo J. A. (1988) In: Advances in Second Messenger Phosphoprotein Research (Greengard P. and Robinson G. A., Eds.) 22, 1-38. Raven Press, New York.
22. Conti M., Jin S. L., Monaco L., Repaske D., Swinnen J. V. Endocr. Rev. 12:1991;218-234.
23. Beavo J., Conti M., Heaslip R. J. Mol. Pharmacol. 46:1994;399-405.
24. Sonnenburg W. K., Beavo J. A. Adv. Pharmacol. 26:1994;87-114.
25. Ohnishi J., Ishido M., Shibata T., Inagami T., Murakami K., Miyasaki H. Biochem. Biophys. Res. Commun. 186(2):1992;1094-1101.
26. Rozengurt E., Murray M., Zachary I., Collins M. Proc. Natl. Acad. Sci. 84:1987;2282-2286.